Sinopharm, China’s biggest pharmaceuticals distributor, and Metallurgical Corp, one of its biggest engineering groups, have raised a combined $3.5bn in initial public offerings in Hong Kong.
The sales, which collected more than the total value of Hong Kong IPOs in the first half of the year, come as a wave of Chinese companies seek to offer new shares in the territory.
